{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:45:55Z","timestamp":1782535555491,"version":"3.54.5"},"reference-count":11,"publisher":"Medical Association of Nippon Medical School","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2026,6,20]]},"DOI":"10.1272\/jnms.jnms.2026_93-312","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T22:08:50Z","timestamp":1782425330000},"page":"211-217","source":"Crossref","is-referenced-by-count":0,"title":["A Guide to Sublingual Immunotherapy in Japan"],"prefix":"10.1272","volume":"93","author":[{"given":"Minoru","family":"Gotoh","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","unstructured":"1. Japan Society of Immunology, Allergology and Infection in Otorhinolaryngology, editor. [2024 Practical Guideline for the Management of Allergic Rhinitis in Japan]. 10th rev. ed. Tokyo: Kanehara Shuppan; 2024. Japanese."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Okamoto Y, Okubo K, Yonekura S, et al. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol. 2015;166 (3):177\u201388.","DOI":"10.1159\/000381059"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gotoh M, Yonekura S, Imai T, et al. Long-term efficacy and dose-finding trial of Japanese cedar pollen sublingual immunotherapy tablet. J Allergy Clin Immunol Pract. 2019 Apr;7 (4):1287\u201397.e8.","DOI":"10.1016\/j.jaip.2018.11.044"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gotoh M, Okubo K, Yuta A, et al. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet. Allergol Int. 2020 Jan;69 (1):104\u201310.","DOI":"10.1016\/j.alit.2019.07.007"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yonekura S, Gotoh M, Kaneko S, Maekawa Y, Okubo K, Okamoto Y. Disease-modifying effect of Japanese cedar pollen sublingual immunotherapy tablets. J Allergy Clin Immunol Pract. 2021 Nov;9 (11):4103\u201316.e14.","DOI":"10.1016\/j.jaip.2021.06.060"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kurokawa T, Yonekura S, Gotoh M, et al. Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis. J Allergy Clin Immunol Glob. 2022 Dec 26;2 (2):100075.","DOI":"10.1016\/j.jacig.2022.10.006"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Gotoh M, Kurokawa T, Yonekura S, et al. Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen. Allergy. 2023 Feb;78 (2):563\u20138.","DOI":"10.1111\/all.15514"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Okamoto Y, Kato M, Ishii K, Sato Y, Hata T, Asaka Y. Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan. Immunotherapy. 2023 Nov;15 (16):1401\u201314.","DOI":"10.2217\/imt-2023-0100"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gotoh M, Maekawa Y, Saito S, Kato N, Horikawa E, Nishino N. Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan. Allergy Asthma Proc. 2025 Jan 1;46 (1):59\u201369.","DOI":"10.2500\/aap.2025.46.240092"},{"key":"10","unstructured":"10. Preparation Committee for the Allergen Immunotherapy Guidelines 2025. [Allergen Immunotherapy Guidelines 2025]. Tokyo: Japanese Society of Allergology; 2025. Japanese."},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Okubo Y, Kuwabara Y, Sato S, Sakashita M, Yuka H, Morita H. Real-world compliance and determinants for sublingual allergen immunotherapy in children and parents. Allergy. 2024 Feb;79 (2):523\u20135.","DOI":"10.1111\/all.15938"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/3\/93_JNMS.2026_93-312\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:04:54Z","timestamp":1782533094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/3\/93_JNMS.2026_93-312\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2026_93-312","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"article-number":"JNMS.2026_93-312"}}